BioBridge Technology Access Network connects high-potential biotech and scientific innovations from Latin America with companies, investors, and strategic partners in Europe — through AI-powered matching, expert advisory, and curated dealflow.
LATAM produces breakthrough research in pharma, biotech, diagnostics, agrotech, and sustainability — but most of it never reaches the global market due to structural disconnection.
We don't just list technologies. We validate, score, match, and activate — with both AI and human expertise at every step.
BioBridge creates value for all sides of the technology transfer equation — with a tailored experience for each participant type.
The BioBridge Readiness Score™ is our proprietary evaluation framework that converts complex scientific assets into a clear, business-readable signal for companies, investors, and strategic partners.
Every technology in BioBridge has been evaluated, scored, and curated by our team. These are live opportunities — not a directory.
Most platforms stop at the introduction. BioBridge stays in the room — from the first match to the signed deal. Our advisory team combines scientific expertise, business strategy, and regulatory knowledge in a rare package.
BioBridge is positioning itself as the primary strategic infrastructure for technology transfer between LATAM and Europe — a market with decades of underinvestment and enormous commercial potential.
Full investment deck, financial model, team profiles, and pipeline data available to qualified investors under NDA.
Whether you're a scientist with a breakthrough technology, a company searching for innovation, or an investor building your deeptech portfolio — BioBridge is your strategic partner.